Heart Attack
Study findings about heart attack are outlined in reports from Johns Hopkins University, U.S.
Published in Cardiovascular Business Week, May 29th, 2007
Study 1: Researchers detail in "Does heart failure etiology, New York Heart Association class, or ejection fraction affect the ability of clopidogrel to inhibit heightened platelet activity," new data in heart failure. "The ability of clopidogrel to inhibit platelet function in patients with congestive heart failure (CHF) was proved by the PLUTO-CHF trial. We retrospectively analyzed platelet characteristics with respect to CHF etiology, class, and ejection fraction in patients enrolled in the PLUTO-CHF study," investigators in the United States report.
"Twenty-five...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Arrhythmia
Arrhythmia Research Technology, Inc. Announces Results for First Quarter 2007 - Asthma
LifeMasters Offers Disease Management Services to Ford Motor Company Employees and United Auto Workers Members - Cardiology
Participants Must Focus On More than Just Pricing to Stay Ahead of Competition in the North American ECG and Cardiac Monitoring Products Markets - Cardiology
Spectral Reports First Quarter Results - Cardiology
The Sorin Group Announces Release of 2007 Cardiac Rhythm Management (CRM) Product Performance Report - Gene Therapy
Cardium Initiates Phase 3 AWARE Clinical Study - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
